NPF is proud to offer free access to the tenth edition of The Psoriasis and Psoriatic Arthritis Pocket Guide: Treatment Algorithms and Management Options. This guide is written by an expert panel of medical professionals and is designed to help healthcare professionals treat patients with psoriasis and psoriatic arthritis.
The Pocket Guide for Psoriasis and Psoriatic Arthritis
The tenth edition of the pocket guide includes updated treatment algorithms, including therapeutic options and related testing, expanded information on the management of psoriatic arthritis, and new chapters on comorbidities and diet and lifestyle recommendations.
Fill out the form below to download your free pocket guide.
Please refresh the page if the form does not load, or contact [email protected] with issues.
The significant progress made in psoriatic disease research since the launch of the National Psoriasis Foundation in 1967 has expanded our knowledge base and led to the development of life-changing treatment options, including:
- Topicals
- Phototherapy
- Biologics
- Oral Treatments
Even with all the information available today, providers may still have questions. For example:
- Are patients with chronic plaque psoriasis candidates for UVB phototherapy?
- Are all systemic treatments also biologics?
- What are the side effects of adalimumab?
Answers to these questions and more are easily accessible in The Psoriasis and Psoriatic Arthritis Pocket Guide: Treatment Algorithms and Management Options.
After studying this handbook, physicians should be able to:
- Define the severity of psoriasis and develop an appropriate therapy plan.
- Explain the profound emotional, social, and physical impact psoriatic disease has on the patient.
- Understand the important comorbidities associated with psoriasis.
- Differentiate psoriasis from other diseases after evaluating patients who present with similar types of skin lesions.
- Diagnose patients who have moderate disease (3% to 10% body involvement) and severe disease (>10% body involvement).
Updated September 2026 by the National Psoriasis Foundation.